635 related articles for article (PubMed ID: 24846275)
1. Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials.
Ford AC; Forman D; Hunt RH; Yuan Y; Moayyedi P
BMJ; 2014 May; 348():g3174. PubMed ID: 24846275
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori eradication for the prevention of gastric neoplasia.
Ford AC; Forman D; Hunt R; Yuan Y; Moayyedi P
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD005583. PubMed ID: 26198377
[TBL] [Abstract][Full Text] [Related]
3. Helicobacter pylori eradication for the prevention of gastric neoplasia.
Ford AC; Yuan Y; Forman D; Hunt R; Moayyedi P
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD005583. PubMed ID: 32628791
[TBL] [Abstract][Full Text] [Related]
4.
Terasawa T; Hamashima C; Kato K; Miyashiro I; Yoshikawa T; Takaku R; Nishida H
BMJ Open; 2019 Sep; 9(9):e026002. PubMed ID: 31542733
[TBL] [Abstract][Full Text] [Related]
5.
Ford AC; Yuan Y; Moayyedi P
Gut; 2020 Dec; 69(12):2113-2121. PubMed ID: 32205420
[TBL] [Abstract][Full Text] [Related]
6. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people.
Ford AC; Gurusamy KS; Delaney B; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003840. PubMed ID: 27092708
[TBL] [Abstract][Full Text] [Related]
7. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
Lee YC; Chiang TH; Chou CK; Tu YK; Liao WC; Wu MS; Graham DY
Gastroenterology; 2016 May; 150(5):1113-1124.e5. PubMed ID: 26836587
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
10. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.
Wong BC; Lam SK; Wong WM; Chen JS; Zheng TT; Feng RE; Lai KC; Hu WH; Yuen ST; Leung SY; Fong DY; Ho J; Ching CK; Chen JS;
JAMA; 2004 Jan; 291(2):187-94. PubMed ID: 14722144
[TBL] [Abstract][Full Text] [Related]
11. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
Ford AC; Delaney BC; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2006 Apr; (2):CD003840. PubMed ID: 16625592
[TBL] [Abstract][Full Text] [Related]
12. Periodontal therapy as adjunctive treatment for gastric Helicobacter pylori infection.
Ren Q; Yan X; Zhou Y; Li WX
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD009477. PubMed ID: 26852297
[TBL] [Abstract][Full Text] [Related]
13. Indications for treatment of Helicobacter pylori infection: a systematic overview.
Veldhuyzen van Zanten SJ; Sherman PM
CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine as an adjuvant therapy for Helicobacter pylori eradication.
Fontes LES; Martimbianco ALC; Zanin C; Riera R
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012357. PubMed ID: 30746681
[TBL] [Abstract][Full Text] [Related]
15. Effects of eradicating Helicobacter pylori on metachronous gastric cancer prevention: A systematic review and meta-analysis.
Fan F; Wang Z; Li B; Zhang H
J Eval Clin Pract; 2020 Feb; 26(1):308-315. PubMed ID: 31141285
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Helicobacter pylori eradication in the prevention of primary gastric cancer in healthy asymptomatic people: A systematic review and meta-analysis comparing risk ratio with risk difference.
Seta T; Takahashi Y; Noguchi Y; Shikata S; Sakai T; Sakai K; Yamashita Y; Nakayama T
PLoS One; 2017; 12(8):e0183321. PubMed ID: 28817628
[TBL] [Abstract][Full Text] [Related]
17. Sequential versus standard triple first-line therapy for Helicobacter pylori eradication.
Nyssen OP; McNicholl AG; Megraud F; Savarino V; Oderda G; Fallone CA; Fischbach L; Bazzoli F; Gisbert JP
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD009034. PubMed ID: 27351542
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of gastric cancer development after
Sugimoto M; Murata M; Yamaoka Y
World J Gastroenterol; 2020 Apr; 26(15):1820-1840. PubMed ID: 32351296
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Epidemiologic Efficacy of Eradicating Helicobacter pylori on Development of Gastric Cancer.
Duan F; Song C; Zhang J; Wang P; Ye H; Dai L; Zhang J; Wang K
Epidemiol Rev; 2019 Jan; 41(1):97-108. PubMed ID: 31497856
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model.
Han Y; Yan T; Ma H; Yao X; Lu C; Li Y; Li L
Dig Dis Sci; 2020 Jun; 65(6):1679-1688. PubMed ID: 31673902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
